In particular, the binding of VLA-4 to its ligand VCAM-1 (vascular cell adhesion molecule 1) was able to interrupt doxorubicin-mediated cell death in T-ALL cell lines. Here, VCAM1 is linked to acute lymphoblastic leukemia.